Ahead of the AI Health Summit in New York City, healthcare executives are preparing for a massive shift in clinical operations. A recent Access Health newsletter preview suggests that the industry is moving from debating AI's capabilities to managing its human consequences.
The mismatch between Stanford's 2025 AI benchmarks and hospital workflows
The speed of technical progress is currently outstripping the ability of medical institutions to implement it safely. According to the Stanford AI Index 2026 report, AI accuracy on advanced reasoning tests reached near-perfect levels in 2025, with benchmarks like SWE-bench Verified jumping from 60% to nearly 100%. Similarly, the OSWorld benchmark saw a dramatic rise from just 6% to 75%.
This rapid evolution creates a systemic tension between cutting-edge software and legacy healthcare structures that were never designed for such volatility. As the report notes, many health systems remain entrenched in decision-making frameworks that cannot accommodate this pace of change.
Who makes the call when an algorithm flags a patient?
The integration of AI into clinical workflows leaves several critical questions unanswered for hospital administrators. As the Access Health report notes, it remains unclear who is ultimately responsible when an algorithm identifies a patient in decline, or how a specialist's role evolves once AI handles their traditional tasks.. The industry is currently grappling with "low-tech" questions regarding the sequence of decision-making and who holds final authority.
Beyond the bedside , the industry must also determine how AI will impact administrative speed.. For example, it is yet to be seen how AI-drafted clinical trial protocols—covering contracting, budgeting, and coverage—will change the cascading effects of AI across entire healthcare systems.
Bill Golden and the shift toward rapid innovation at Anterior
The conversation around AI is also moving into the insurance and payer sectors, a space traditionally characterized by secrecy. Bill Golden, the former CEO of UnitedHealth's employer and individual businesses, is now providing rare insights into these strategies through his work with the AI startup Anterior.
Through Anterior's "Build Faster Horses" campaign, the company is signaling a move away from incremental improvements toward a culture of radical innovation within the insurer ecosystem. this shift aims to integrate AI seamlessly into existing governance structures and decision-making hierarchies rather than treating it as a standalone tool.
Moving from tool procurement to MD Anderson's experimentation model
Rather than engaging in a race to buy the same tools as competitors, Dan Shoenthal, the chief innovation officer at MD Anderson Cancer Center, advocates for a strategy of localized experimentation. Shoenthal suggests that because technology firms evolve faster than health systems, leaders must evaluate what "good" looks like within their own specific clinical contexts.
Instead of simply purchasing the next available tool, he urges executives to share lessons learned to navigate the "rough terrain" of implementation. These practical, human-centric lessons are expected to be a focal point during a "Pulse Check" session at the upcoming AI Health Summit in New York City.
Comments 0